Category: biotech

.After antibody-drug conjugate (ADC) specialist Seagen was actually marketed to Pfizer in 2013 for a tremendous $43 billion, former chief executive officer David Epstein claimed

.Amid the genetic medicines branches nationality, Flagship Pioneering is actually unveiling a new company to aid biotechs make improvements the precision of their treatments.The project

.Intense Biotech Colleague Publisher Gabrielle Masson presented the 2024 class of Fierce 15 champions on the flooring of the Stock market on Wednesday.Masson appeared on

.Allow’s dive into a conversation along with Ayla Ellison, Tough Biotech Editor-in-Chief and Michelle Benz as they explain the highlights and enjoyment encompassing this year’s

.FibroGen is actually substantially reorganizing its own business, laying off 75% of its USA personnel as well as stopping investment in its lead prospect in

.After F2G’s initial attempt to obtain a brand-new training class of antifungal to market was wrecked due to the FDA, the U.K.-based biotech has actually

.The FDA has implemented a predisposed hold on a phase 3 non-small mobile bronchi cancer cells dry run by BioNTech and also OncoC4 after observing

.After dismissing the selection date for Applied Rehabs’ metabolic condition medication govorestat, the FDA has actually currently determined that a considered advisory committee conference won’t

.For Lykos Rehabs and the firm’s prospective MDMA-assisted therapy for trauma (POST-TRAUMATIC STRESS DISORDER), the smash hits simply keep coming..Previously this month, Lykos was hit

.5 months after accepting Electrical Therapies’ Pivya as the 1st new treatment for easy urinary tract infections (uUTIs) in much more than two decades, the